How IV fluids before birth affect newborn weight loss
Part of Lungs & breathing clinical trials.
This trial looks at whether giving IV fluids to mothers before delivery affects how much weight healthy, full-term newborns lose in their first days of life. It is for mothers who feed their baby only formula in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born full-term (at least 37 weeks)
- You had a single baby (not twins or more)
- You are 18 years or older
- You are only feeding your baby formula (no breastfeeding) in the hospital for the first 2 days
- You did not need extra IV fluids for a health problem in the 12 hours before giving birth
- Your baby does not have a kidney problem or a cleft lip/palate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how very small premature babies (born early and weighing less than 4.4 pounds at discharge) do after they go home. It helps doctors understand what support families need.
This trial tests whether a special technique to insert a catheter into the umbilical vein (through Wharton's jelly) can help deliver emergency medications faster to newborns who need resuscitation. It might be an option for full-term babies in critical distress who need adrenaline immediately.
This study looks at when to stop IV nutrition (parenteral nutrition) for babies born weighing less than 1500 grams (about 3.3 pounds). It tests if stopping IV nutrition earlier or later affects growth and development, and how a growth factor called IGF-1 relates to this. The goal is to help these tiny babies grow better.
This study tests whether adding extra nutrients (fortification) to human milk helps very low birth weight or preterm babies grow better in the NICU.
This trial compares giving less fluid versus the usual amount to very early preterm babies to see if it helps prevent bronchopulmonary dysplasia, a chronic lung condition. The goal is to find the safest way to manage fluids and protect their developing lungs.
This trial tests whether giving an omega-3 fat medicine through an IV (along with standard care) improves breathing and blood-flow problems in newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. It may help reduce strain on the lungs and heart by targeting inflammation and blood-vessel changes.
Hear when a new Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.